Molecular profiling of a case of advanced pancreatic cancer identifies an active and tolerable combination of targeted therapy with backbone chemotherapy

Journal of Gastrointestinal Oncology

Nader Javadi³  Ari Vanderwalde²  Sandeep Bobby Reddy¹  Benny Johnson²  Rebecca Feldman¹ 

[1] The University of Tennessee Health Science Center and West Cancer Center, Memphis, TN 38120, USAThe University of Tennessee Health Science Center and West Cancer Center, Memphis, TN 38120, USAThe University of Tennessee Health Science Center and West Cancer Center, Memphis, TN 38120, USA;Hope Health Center, Reseda, CA, USAHope Health Center, Reseda, CA, USAHope Health Center, Reseda, CA, USA

关键词: Metastatic pancreatic cancer;    molecular profiling;    targeted therapy;   

DOI  :  10.3978/j.issn.2078-6891.2015.091

学科分类：肿瘤学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown